Effect of COVID 19 vaccination on the CT severity score for SARS CoV2 pneumonia- an experience from the initial wave.

Radhika Batra, Sneha Harish C, Swati Gupta, Anju Garg
{"title":"Effect of COVID 19 vaccination on the CT severity score for SARS CoV2 pneumonia- an experience from the initial wave.","authors":"Radhika Batra, Sneha Harish C, Swati Gupta, Anju Garg","doi":"10.15392/2319-0612.2023.2279","DOIUrl":null,"url":null,"abstract":"The severe acute respiratory syndrome coronavirus 2 pandemic started in the December of 2019 at China. The second wave of the pandemic in India peaked between April-May 2021. In order to reduce the transmission and infectivity of the virus several vaccines were approved for emergent use. Studies have shown the effectiveness of vaccination in reducing the clinical severity of infection by the corona virus. In this study we aim to assess the effect of vaccination on the computed tomography severity score (CTSS). The study included 140 patients who tested positive for COVID 19 on RT PCR or rapid antigen test. Seventy of these patients had received at least one dose of vaccination and 70 patients were unvaccinated.  CT scan of the chest was done for all patients and a CTSS ranging from 0 to 25 was assigned depending on the extent of lobar involvement. We found that a higher percentage (72.86%) of unvaccinated patients had severe disease compared to the vaccinated group (38.57%), 5.71% of unvaccinated patients had mild disease compared to 30% of vaccinated patients. The difference between the two groups was found to be statistically significant. On comparing the CTSS of patients with and without vaccination in our study, we found a significant reduction in the severity scores in the vaccinated group. Through this study the vaccine’s efficacy could be validated objectively. This article aims to emphasize the role of vaccination in our fight against the pandemic caused by the corona virus.","PeriodicalId":9203,"journal":{"name":"Brazilian Journal of Radiation Sciences","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2023-07-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Brazilian Journal of Radiation Sciences","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.15392/2319-0612.2023.2279","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

The severe acute respiratory syndrome coronavirus 2 pandemic started in the December of 2019 at China. The second wave of the pandemic in India peaked between April-May 2021. In order to reduce the transmission and infectivity of the virus several vaccines were approved for emergent use. Studies have shown the effectiveness of vaccination in reducing the clinical severity of infection by the corona virus. In this study we aim to assess the effect of vaccination on the computed tomography severity score (CTSS). The study included 140 patients who tested positive for COVID 19 on RT PCR or rapid antigen test. Seventy of these patients had received at least one dose of vaccination and 70 patients were unvaccinated.  CT scan of the chest was done for all patients and a CTSS ranging from 0 to 25 was assigned depending on the extent of lobar involvement. We found that a higher percentage (72.86%) of unvaccinated patients had severe disease compared to the vaccinated group (38.57%), 5.71% of unvaccinated patients had mild disease compared to 30% of vaccinated patients. The difference between the two groups was found to be statistically significant. On comparing the CTSS of patients with and without vaccination in our study, we found a significant reduction in the severity scores in the vaccinated group. Through this study the vaccine’s efficacy could be validated objectively. This article aims to emphasize the role of vaccination in our fight against the pandemic caused by the corona virus.
COVID - 19疫苗接种对SARS - CoV2肺炎CT严重程度评分的影响——来自初始波的经验
新冠肺炎疫情于2019年12月在中国爆发。印度的第二波大流行在2021年4月至5月期间达到顶峰。为了减少病毒的传播和传染性,已批准紧急使用几种疫苗。研究表明,接种疫苗可有效降低冠状病毒感染的临床严重程度。在这项研究中,我们旨在评估疫苗接种对计算机断层扫描严重程度评分(CTSS)的影响。该研究包括140名经RT - PCR或快速抗原检测呈阳性的患者。其中70名患者至少接种了一剂疫苗,70名患者未接种疫苗。所有患者均进行胸部CT扫描,根据大叶受累程度,CTSS评分从0到25。我们发现,未接种疫苗的患者患重症的比例(72.86%)高于接种疫苗组(38.57%),未接种疫苗的患者患轻度疾病的比例(5.71%)高于接种疫苗组(30%)。两组之间的差异有统计学意义。在我们的研究中,通过比较接种疫苗和未接种疫苗的患者的CTSS,我们发现接种疫苗组的严重程度评分显著降低。通过本研究,可以客观地验证疫苗的有效性。本文旨在强调疫苗接种在我们抗击冠状病毒引起的大流行中的作用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信